Landmark Clinical Trial Unlocks New Strategy to Prevent Breast Cancer Recurrence by Targeting Dormant Cells
Billy Candra A groundbreaking, federally funded clinical trial, the first of its kind, has achieved a significant...
Billy Candra
Doctors just found a way to slow one of the deadliest prostate cancers
A landmark international study, spearheaded by researchers at University College London (UCL), has unveiled a...
Unraveling the Gut-Heart Connection: Seoul Researchers Map Microbiome’s Intricate Role in Coronary Artery Disease, Paving Way for Precision Prevention
Cardiovascular diseases (CVDs) stand as the paramount global health challenge, claiming an staggering nearly 20...
Personalized Breast Cancer Screening Proves Safer and More Effective Than One-Size-Fits-All Approach, Landmark WISDOM Study Reveals
A large new study suggests that tailoring breast cancer screening to a woman’s individual risk...
Ibuprofen: The Everyday Painkiller Under the Spotlight for Unexpected Anti-Cancer Potential
Ibuprofen, a ubiquitous non-steroidal anti-inflammatory drug (NSAID) found in medicine cabinets worldwide, is increasingly drawing...
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Scientists at the Icahn School of Medicine at Mount Sinai have unveiled an experimental immunotherapy...
Why colorectal cancer breaks the immune system’s rules
In the complex landscape of oncology, a groundbreaking study from the Sloan Kettering Institute at...
A Critical Epigenetic Switch: GATA6 Loss Drives Colorectal Cancer Liver Metastasis, Offering New Diagnostic and Therapeutic Avenues
Researchers at Weill Cornell Medicine and the Massachusetts Institute of Technology have identified a key...
Groundbreaking Research Uncovers Dual Nature of Immune Cells in Colorectal Cancer, Paving Way for Targeted Immunotherapies
A pivotal new study by researchers at the Sloan Kettering Institute (SKI) at Memorial Sloan...
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Scientists at the Icahn School of Medicine at Mount Sinai have unveiled a groundbreaking experimental...
